• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柬埔寨恶性疟原虫和间日疟原虫感染患者中的葡萄糖-6-磷酸脱氢酶缺乏症

G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.

作者信息

Khim Nimol, Benedet Christophe, Kim Saorin, Kheng Sim, Siv Sovannaroth, Leang Rithea, Lek Soley, Muth Sinuon, Chea Nguon, Chuor Char Meng, Duong Socheat, Kerleguer Alexandra, Tor Pety, Chim Pheaktra, Canier Lydie, Witkowski Benoit, Taylor Walter R J, Ménard Didier

出版信息

Malar J. 2013 May 28;12:171. doi: 10.1186/1475-2875-12-171.

DOI:10.1186/1475-2875-12-171
PMID:23714236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3671135/
Abstract

BACKGROUND

Glucose-6-phosphate-dehydrogenase deficiency (G6PDd) rates are unknown in malaria-infected Cambodian patients. These data are key to a rational drug policy for malaria elimination of Plasmodium falciparum and Plasmodium vivax.

METHODS

From September 2010-2012, a two-year survey of G6PDd and haemoglobinopathies assessed by quantitative enzyme activity assay and haemoglobin electrophoresis, respectively, was conducted in malaria-infected patients presenting to 19 health centres throughout Cambodia.

RESULTS

A total of 2,408 confirmed malaria patients of mean age 26.7 (range 2-81) years were recruited from mostly western Cambodia (n = 1,732, 71.9%); males outnumbered females by 3.9:1. Plasmodium falciparum was present in 1,443 (59.9%) and P. vivax in 965 (40.1%) patients. Mean G6PD activity was 11.6 (CI 95%: 11.4-11.8) U/g Hb, G6PDd was present in 13.9% of all patients (335/2,408) and severe G6PDd (including WHO Class I and II variants) was more common in western (158/1,732, 9.1%) versus eastern (21/414, 5.1%) Cambodia (P = 0.01). Of 997/2,408 (41.4%) had a haemoglobinopathy. Mean haemoglobin concentrations were inversely related to age: 8.1 g/dL < five years, 8.7 g/dL five to 14 years, and 10.4 g/dL >15 years (P <0.001).

CONCLUSIONS

G6PDd prevalence, anaemia and haemoglobinopathies were common in malaria-infected patients. The deployment of primaquine in Cambodia should be preceded by primaquine safety studies paralleled with evaluations of easy to use tests to detect G6PDd.

摘要

背景

柬埔寨疟疾感染患者中葡萄糖-6-磷酸脱氢酶缺乏症(G6PDd)的发生率尚不清楚。这些数据是制定消除恶性疟原虫和间日疟原虫疟疾合理药物政策的关键。

方法

2010年9月至2012年,对柬埔寨各地19个卫生中心的疟疾感染患者进行了为期两年的G6PDd和血红蛋白病调查,分别通过定量酶活性测定和血红蛋白电泳进行评估。

结果

共招募了2408例确诊疟疾患者,平均年龄26.7岁(范围2至81岁),大多来自柬埔寨西部(n = 1732,71.9%);男性与女性的比例为3.9:1。1443例(59.9%)患者感染恶性疟原虫,965例(40.1%)患者感染间日疟原虫。平均G6PD活性为11.6(95%置信区间:11.4 - 11.8)U/g Hb,所有患者中13.9%(335/2408)存在G6PDd,严重G6PDd(包括世界卫生组织I类和II类变体)在柬埔寨西部(158/1732,9.1%)比东部(21/414,5.1%)更常见(P = 0.01)。2408例中有997例(41.4%)患有血红蛋白病。平均血红蛋白浓度与年龄呈负相关:5岁以下为8.1 g/dL,5至14岁为8.7 g/dL,15岁以上为10.4 g/dL(P <0.001)。

结论

G6PDd患病率、贫血和血红蛋白病在疟疾感染患者中很常见。在柬埔寨使用伯氨喹之前,应先进行伯氨喹安全性研究,并同时评估易于使用的检测G6PDd的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/39d24cccfe96/1475-2875-12-171-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/e5d02997aabd/1475-2875-12-171-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/5002db22431d/1475-2875-12-171-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/daeae8474446/1475-2875-12-171-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/1e542f5c7ae1/1475-2875-12-171-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/39d24cccfe96/1475-2875-12-171-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/e5d02997aabd/1475-2875-12-171-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/5002db22431d/1475-2875-12-171-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/daeae8474446/1475-2875-12-171-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/1e542f5c7ae1/1475-2875-12-171-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4908/3671135/39d24cccfe96/1475-2875-12-171-5.jpg

相似文献

1
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.柬埔寨恶性疟原虫和间日疟原虫感染患者中的葡萄糖-6-磷酸脱氢酶缺乏症
Malar J. 2013 May 28;12:171. doi: 10.1186/1475-2875-12-171.
2
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.每周一次伯氨喹对柬埔寨葡萄糖-6-磷酸脱氢酶缺乏症患者间日疟复发的耐受性和安全性
BMC Med. 2015 Aug 25;13:203. doi: 10.1186/s12916-015-0441-1.
3
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.葡萄糖-6-磷酸脱氢酶缺乏和正常的恶性疟原虫感染的柬埔寨人中单次低剂量磷酸萘酚喹的耐受性。
BMC Infect Dis. 2019 Mar 12;19(1):250. doi: 10.1186/s12879-019-3862-1.
4
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.接受每周伯氨喹治疗间日疟原虫疟疾患者的 G6PD 活性动力学。
PLoS Negl Trop Dis. 2021 Sep 8;15(9):e0009690. doi: 10.1371/journal.pntd.0009690. eCollection 2021 Sep.
5
G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.巴西亚马逊西部疟疾流行地区的葡萄糖-6-磷酸脱氢酶(G6PD)缺乏等位基因
Malar J. 2017 Jun 15;16(1):253. doi: 10.1186/s12936-017-1889-6.
6
The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on haemoglobin levels in Ethiopia: a longitudinal cohort study.单剂低剂量磷酸萘酚喹治疗无并发症恶性疟原虫疟疾对埃塞俄比亚血红蛋白水平的影响:一项纵向队列研究。
Malar J. 2024 Jul 12;23(1):208. doi: 10.1186/s12936-024-05021-x.
7
Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.埃塞俄比亚西南部甘贝拉医院疟疾疑似患者中的葡萄糖-6-磷酸脱氢酶缺乏症
Malar J. 2014 Nov 18;13:438. doi: 10.1186/1475-2875-13-438.
8
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症、伯氨喹治疗与疟疾感染患者溶血性贫血风险
Malar J. 2018 Nov 8;17(1):415. doi: 10.1186/s12936-018-2564-2.
9
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.影响用单剂低剂量伯氨喹或安慰剂治疗的无并发症急性恶性疟原虫疟疾非洲儿童血红蛋白动态变化的因素。
BMC Med. 2023 Oct 20;21(1):397. doi: 10.1186/s12916-023-03105-0.
10
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.哥伦比亚疟疾流行地区葡萄糖-6-磷酸脱氢酶缺乏症的患病率及基因变异
Malar J. 2016 May 26;15(1):291. doi: 10.1186/s12936-016-1343-1.

引用本文的文献

1
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.影响用单剂低剂量伯氨喹或安慰剂治疗的无并发症急性恶性疟原虫疟疾非洲儿童血红蛋白动态变化的因素。
BMC Med. 2023 Oct 20;21(1):397. doi: 10.1186/s12916-023-03105-0.
2
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China.葡萄糖-6-磷酸脱氢酶缺乏症(G6PDd)的流行情况及其在中国海南省疟疾流行地区安全使用伯氨喹的临床意义。
Front Public Health. 2022 Oct 21;10:1010172. doi: 10.3389/fpubh.2022.1010172. eCollection 2022.
3

本文引用的文献

1
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.葡萄糖-6-磷酸脱氢酶缺乏症检测关键知识空白的综述:安全临床部署 8-氨基喹啉治疗方案的角度:一份研讨会报告。
Malar J. 2013 Mar 27;12:112. doi: 10.1186/1475-2875-12-112.
2
G6PD deficiency: global distribution, genetic variants and primaquine therapy.葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症:全球分布、遗传变异和伯氨喹治疗。
Adv Parasitol. 2013;81:133-201. doi: 10.1016/B978-0-12-407826-0.00004-7.
3
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting.
Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency among Malaria Patients in Southern Thailand: 8 Years Retrospective Study.
泰国南部地区疟疾患者葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的流行情况:8 年回顾性研究。
Korean J Parasitol. 2022 Feb;60(1):15-23. doi: 10.3347/kjp.2022.60.1.15. Epub 2022 Feb 23.
4
In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative.新型青蒿素衍生物FM-AZ的体外和计算机模拟抗疟评估
Medicines (Basel). 2022 Jan 24;9(2):8. doi: 10.3390/medicines9020008.
5
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.葡萄糖-6-磷酸脱氢酶缺乏症(G6PDd)的流行情况、CareStart 定性快速诊断检测的性能以及苏丹两个疟疾流行地区的遗传变异。
PLoS Negl Trop Dis. 2021 Oct 26;15(10):e0009720. doi: 10.1371/journal.pntd.0009720. eCollection 2021 Oct.
6
Genotypic glucose-6-phosphate dehydrogenase (G6PD) deficiency protects against Plasmodium falciparum infection in individuals living in Ghana.基因型葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症可保护加纳居民免受恶性疟原虫感染。
PLoS One. 2021 Sep 27;16(9):e0257562. doi: 10.1371/journal.pone.0257562. eCollection 2021.
7
Impairment of Invasion and Maturation and Decreased Selectivity of Plasmodium falciparum in G6PD Viangchan and Mahidol Variants.G6PD Viangchan 和 Mahidol 变异体导致疟原虫入侵和成熟受损以及选择性降低。
J Infect Dis. 2022 Apr 1;225(7):1238-1247. doi: 10.1093/infdis/jiab484.
8
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.接受每周伯氨喹治疗间日疟原虫疟疾患者的 G6PD 活性动力学。
PLoS Negl Trop Dis. 2021 Sep 8;15(9):e0009690. doi: 10.1371/journal.pntd.0009690. eCollection 2021 Sep.
9
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against malaria.地中海型葡萄糖-6-磷酸脱氢酶缺乏症对疟疾的保护作用。
Elife. 2021 Feb 5;10:e62448. doi: 10.7554/eLife.62448.
10
Qualitative and quantitative assay of glucose 6 phosphate dehydrogenase in patients attending tertiary care center.对三级护理中心就诊患者的葡萄糖-6-磷酸脱氢酶进行定性和定量检测。
BMC Res Notes. 2020 Jun 22;13(1):298. doi: 10.1186/s13104-020-05145-8.
世界卫生组织疟疾政策咨询委员会:2012 年 9 月会议的结论和建议。
Malar J. 2012 Dec 19;11:424. doi: 10.1186/1475-2875-11-424.
4
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.G6PD 缺乏症在疟疾流行国家的流行率和受影响人群估计:基于地统计学模型的地图。
PLoS Med. 2012;9(11):e1001339. doi: 10.1371/journal.pmed.1001339. Epub 2012 Nov 13.
5
Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia.集中筛查和治疗(FSAT):一种基于 PCR 的策略,用于检测疟原虫携带者并控制耐药性的恶性疟原虫、柬埔寨拜林。
PLoS One. 2012;7(10):e45797. doi: 10.1371/journal.pone.0045797. Epub 2012 Oct 1.
6
Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance.柬埔寨消除恶性疟原虫疟疾的优化策略:伯氨喹、大规模药物治疗和抗青蒿素。
PLoS One. 2012;7(5):e37166. doi: 10.1371/journal.pone.0037166. Epub 2012 May 25.
7
Global malaria mortality between 1980 and 2010: a systematic analysis.全球疟疾死亡率 1980 年至 2010 年:系统分析。
Lancet. 2012 Feb 4;379(9814):413-31. doi: 10.1016/S0140-6736(12)60034-8.
8
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.CareStart™ G6PD 缺乏症筛查检测在以青蒿素为基础的联合疗法中用于筛查伯氨喹用药的表现。
PLoS One. 2011;6(12):e28357. doi: 10.1371/journal.pone.0028357. Epub 2011 Dec 2.
9
The threat of artemisinin-resistant malaria.耐青蒿素疟疾的威胁。
N Engl J Med. 2011 Sep 22;365(12):1073-5. doi: 10.1056/NEJMp1108322.
10
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.在坦桑尼亚,与青蒿素联合使用一剂伯氨喹后发生的溶血并不仅限于葡萄糖-6-磷酸脱氢酶缺乏症(G6PD A-)个体。
Antimicrob Agents Chemother. 2010 May;54(5):1762-8. doi: 10.1128/AAC.01135-09. Epub 2010 Mar 1.